CHPA leadership
This article was originally published in The Tan Sheet
Executive Summary
Interim head expected to be named week of Dec. 10. Appointment will provide trade group with guidance during its search for a full-time president, board of directors notes. Permanent head expected by mid-2002. Rockville, Md.-based JDG Associates, which conducted search two years ago leading to selection of Michael Maves, MD, will again be used by CHPA. Maves is leaving for American Medical Association top post Jan. 15 (1"The Tan Sheet" Nov. 26, p. 3)...
You may also be interested in...
CHPA Has Experienced Senior VP Corps To Cover In Maves Transition
The Consumer Healthcare Products Association has a senior staff cadre with almost 100 years of experience to run the OTC/dietary supplement trade association during the search for a new director in the wake of the departure of Michael Maves, MD
Can Organovo Leverage Its Solid Phase II Data In MASH?
Cash-limited Organovo has an FXR agonist showing competitive efficacy and tolerability in MASH, but may need a partner to move forward in that disease as it may be prioritizing its IBD program.
Cullinan Changes Tracks, Moving Lymphoma Bispecific Into Autoimmune
The company will discontinue its trial of the CD19-directed bispecific CLN-978 in NHL and develop it in inflammatory diseases, where it could have an edge over CAR-Ts.